From the Department of Surgery, Faculty of Medicine, Ongkharak Campus, Srinakharinwirot University, Ongkaharak, Nakhon Nayok, Thailand.
Ann Saudi Med. 2022 Sep-Oct;42(5):343-350. doi: 10.5144/0256-4947.2022.343. Epub 2022 Oct 6.
Arteriovenous graft infection (AVGI) is a major cause of hemodialysis access failure. Delayed diagnosis and inappropriate treatment may lead to increased morbidity (3-35%) and mortality up to 12%.
Compare the postoperative outcomes of total graft excision (TGE) and partial graft excision (PGE) in the treatment of AVGI.
Systematic review and meta-analysis METHODS: The dataset was defined by searching PubMed, EMBASE, Google Scholar, and the Cochrane database for articles outlining the terms arteriovenous graft infection, infected dialysis graft, TGE and PGE published between 1995-2020. The data analysis evaluated the outcomes of TGE and PGE in the management of AVGI. The meta-analysis was performed using Review Manager Software version 5.4.1.
30-day mortality, recurrent infection, and reoperation rate.
Eight studies, including 555 AVGI, and 528 patients.
PGE showed a significant increase in recurrent graft infection rate (OR=0.23,95% CI=0.13-0.41, <.00001) and re-operation rate for control of infection (OR=0.14,95% CI=0.03-0.58, <.007). However, the 30-day mortality rate did not differ significantly between the groups (OR=0.92,95% CI=0.39-2.17, =.85).
TGE remains a safe and effective surgical method for the management of AVGI. PGE is associated with a higher risk of graft infection and need for re-operation. As a result, PGE should only be considered in carefully selected patients.
Risk of bias due to the differences in patient characteristics.
None.
动静脉移植物感染(AVGI)是血液透析通路失败的主要原因。延迟诊断和不适当的治疗可能会导致发病率增加(3-35%),死亡率高达 12%。
比较全移植物切除(TGE)和部分移植物切除(PGE)治疗 AVGI 的术后结果。
系统评价和荟萃分析
通过搜索 PubMed、EMBASE、Google Scholar 和 Cochrane 数据库,确定了自 1995 年至 2020 年期间,使用“动静脉移植物感染”、“感染性透析移植物”、“TGE”和“PGE”等术语描述的文章数据集。数据分析评估了 TGE 和 PGE 在 AVGI 管理中的结果。使用 Review Manager Software 版本 5.4.1 进行荟萃分析。
30 天死亡率、复发性感染和再次手术率。
8 项研究,包括 555 例 AVGI 和 528 例患者。
PGE 组复发性移植物感染率显著增加(OR=0.23,95%CI=0.13-0.41,<.00001),控制感染的再次手术率也显著增加(OR=0.14,95%CI=0.03-0.58,<.007)。然而,两组间 30 天死亡率无显著差异(OR=0.92,95%CI=0.39-2.17,=.85)。
TGE 仍然是治疗 AVGI 的安全有效的手术方法。PGE 与移植物感染和再次手术的风险增加相关。因此,仅应在仔细选择的患者中考虑 PGE。
由于患者特征的差异,存在偏倚风险。
无。